Panacea Index Logo

Command Palette

Search for a command to run...

Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kappaB.

FEBS letters
January 8, 1999
K Riehemann et al. (3 authors)
Journal ArticleHuman StudyMolecular Study
Study Details

Study Goal

The researchers aimed to determine whether stinging nettle extract (IDS23) inhibits NF-kappaB activation, a key pathway in chronic inflammation.

Results Summary

The study found that IDS23 potently inhibits NF-kappaB activation by preventing degradation of its inhibitory subunit IkappaB-alpha, suggesting a mechanism for its anti-inflammatory effects. The effect was observed across multiple cell types and stimuli.

Population

In vitro cell studies (no human or animal subjects specified).

Effective Dosage

Not specified.

Duration

Not specified.

Interactions

None mentioned.

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Extracts from leaves of stinging nettle (Urtica dioica)
decrease
rheumatoid arthritis
null
null
are used as antiinflammatory remedies
#1
Standardized preparations of these extracts (IDS23)
decrease
cytokine production
null
null
suppress
#2
treatment of different cells with IDS23
decrease
NF-kappaB activation
different cells
null
potently inhibits
#3
IDS23
decrease
a common NF-kappaB pathway
null
null
suppressed
#4
IDS23
no change
its inhibitory subunit IkappaB-alpha
null
null
preventing degradation
#5
Urtica extract
decrease
NF-kappaB activation
null
null
inhibitory effect
#6
Abstract

Activation of transcription factor NF-kappaB is elevated in several chronic inflammatory diseases and is responsible for the enhanced expression of many proinflammatory gene products. Extracts from leaves of stinging nettle (Urtica dioica) are used as antiinflammatory remedies in rheumatoid arthritis. Standardized preparations of these extracts (IDS23) suppress cytokine production, but their mode of action remains unclear. Here we demonstrate that treatment of different cells with IDS23 potently inhibits NF-kappaB activation. An inhibitory effect was observed in response to several stimuli, suggesting that IDS23 suppressed a common NF-kappaB pathway. Inhibition of NF-kappaB activation by IDS23 was not mediated by a direct modification of DNA binding, but rather by preventing degradation of its inhibitory subunit IkappaB-alpha. Our results suggests that part of the antiinflammatory effect of Urtica extract may be ascribed to its inhibitory effect on NF-kappaB activation.

Medical Subject Headings (MeSH)
AnimalsAntirheumatic AgentsArthritis, RheumatoidCell LineDNA-Binding ProteinsGene Expression RegulationHeLa CellsHumansI-kappa B ProteinsInflammation MediatorsJurkat CellsMiceNF-KappaB Inhibitor alphaNF-kappa BPlant ExtractsPlants, Medicinal
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations118
Citations/Year4.5
Relative Citation Ratio3.44
NIH Percentile87.6%
Research Impact Scores
APT Score0.25
Weight Score0.33
Normalized Score0.69
Related Supplements